A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia
Clinical trial NCT01670071 · TERMINATED
Trial details
- NCT number
- NCT01670071
- Sponsor
- Johnson & Johnson Taiwan Ltd
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.